Eurofins Scientific SE Stock
Stocks
ERF
FR0014000MR3
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 68.96 EUR | +1.00% |
|
+10.30% | +10.51% |
| 06-05 | Eurofins Scientific SE acquired High North Laboratories. | CI |
| 05-14 | Eurofins Scientific SE Develops And Offers New Solutions For Hantavirus Detection | CI |
| Market Cap | 12.05B 13.74B 11.11B 10.4B 19.5B 1,297B 19.91B 134B 51.66B 641B 51.61B 50.48B 2,222B | P/E 2026 * |
23.9x | P/E 2027 * | 18.4x |
|---|---|---|---|---|---|
| Enterprise Value | 15.49B 17.67B 14.28B 13.37B 25.07B 1,667B 25.59B 172B 66.42B 824B 66.35B 64.9B 2,857B | EV / Sales 2026 * |
2.04x | EV / Sales 2027 * | 1.87x |
| Free-Float |
58.35% | Yield 2026 * |
1.12% | Yield 2027 * | 1.3% |
Last Transcript: Eurofins Scientific SE
| 1 day | +1.00% | ||
| 1 week | +10.30% | ||
| Current month | +10.41% | ||
| 1 month | +11.30% | ||
| 3 months | +11.59% | ||
| 6 months | +10.98% | ||
| Current year | +10.51% |
| 1 week | 62.16 |  | 68.96 |
| 1 month | 60.76 | | 68.96 |
| Current year | 56.84 | | 74.32 |
| 1 year | 54.86 | | 74.32 |
| 3 years | 39.47 | | 74.32 |
| 5 years | 39.47 | | 127.68 |
| 10 years | 29.82 | | 127.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 63 | 01/01/1987 |
Laurent Lebras
DFI | Director of Finance/CFO | - | 01/01/2015 |
Christian Wurst
PRN | Corporate Officer/Principal | 53 | 01/10/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CHM | Chairman | 63 | 01/01/1987 |
Yves-Loïc Martin
BRD | Director/Board Member | 60 | 01/01/2015 |
Valérie Hanote
BRD | Director/Board Member | 60 | 01/01/1990 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-27 | Buy | 700 | 0.0004% | |||
| 04-19 | Sell | Chief Financial Officer | 3,000 | 0.0016% | ||
| 04-19 | Sell | 3,000 | 0.0016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.00% | +10.30% | +13.31% | +22.84% | 13.74B | |
| -0.48% | +7.20% | -5.08% | +2.45% | 46.2B | |
| +2.19% | +11.71% | +385.81% | +632.13% | 38.71B | |
| +2.53% | +13.93% | +20.85% | -10.61% | 31.9B | |
| +1.65% | +3.61% | +9.98% | +55.42% | 31.12B | |
| -4.16% | -2.58% | +8.74% | +15.22% | 23.77B | |
| -0.32% | +12.96% | - | - | 16.2B | |
| +1.37% | +14.53% | +71.80% | +134.14% | 15.05B | |
| +3.63% | +9.53% | +104.07% | +107.62% | 13.42B | |
| +5.53% | +16.34% | +15.75% | -25.73% | 13.01B | |
| Average | +1.29% | +9.86% | +69.47% | +103.72% | 24.31B | |
| Weighted average by Cap. | +1.01% | +9.12% | +82.62% | +131.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.6B 8.67B 7.01B 6.56B 12.3B 818B 12.55B 84.2B 32.58B 404B 32.55B 31.84B 1,401B | 8.07B 9.21B 7.44B 6.97B 13.07B 869B 13.34B 89.45B 34.61B 429B 34.58B 33.82B 1,489B |
| Net income | 517M 589M 476M 446M 836M 55.59B 853M 5.72B 2.21B 27.47B 2.21B 2.16B 95.26B | 676M 771M 623M 583M 1.09B 72.75B 1.12B 7.49B 2.9B 35.95B 2.9B 2.83B 125B |
| Net Debt | 3.44B 3.93B 3.17B 2.97B 5.57B 370B 5.69B 38.13B 14.76B 183B 14.74B 14.42B 635B | 3.08B 3.52B 2.84B 2.66B 4.99B 332B 5.1B 34.17B 13.22B 164B 13.21B 12.92B 569B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/06/26 | €68.96 | +1.00% | 204,095 |
| 25/06/26 | €68.28 | +1.88% | 264,566 |
| 24/06/26 | €67.02 | +2.73% | 305,277 |
| 23/06/26 | €65.24 | +2.77% | 320,692 |
| 22/06/26 | €63.48 | +1.54% | 313,305 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ERF Stock
Select your edition
All financial news and data tailored to specific country editions
